|Application ||WB, IHC-P|
|Calculated MW||18392 Da|
|Purification||Antisera to human BAD were raised by repeated immunisation of rabbits with highly purified antigen.|
|Immunogen||Human BAD fusion protein.|
|Shelf Life||18 months from date of despatch.|
|Other Names||Bcl2-associated agonist of cell death, BAD, Bcl-2-binding component 6, Bcl-2-like protein 8, Bcl2-L-8, Bcl-xL/Bcl-2-associated death promoter, Bcl2 antagonist of cell death, BAD, BBC6, BCL2L8|
|Target/Specificity||Rabbit anti-Human BAD antibody recognizes the human BAD protein, a member of the Bcl-2 family of apoptosis related proteins.BAD acts as a cell death promoter, and may form heterodimers with Bcl-2 or with Bcl-XL.|
|Preservative & Stabilisers||0.09% Sodium Azide|
|Storage||Store at +4℃ or at -20 ℃.|
|Precautions||Anti-Human BAD Antibody (Serum) is for research use only and not for use in diagnostic or therapeutic procedures.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
1. Combaret, V. et al. (2008) Effect of bortezomib on human neuroblastoma: analysis of molecular mechanisms involved in cytotoxicity.Mol Cancer. 7: 50. 2. Al-Bazz, Y.O. et al. (2009) Prognostic significance of Akt, phospho-Akt and BAD expression in primary breast cancer.Eur. J. Cancer 45: 694-704. 3. Dalle, S. (2009) In vivo model of follicular lymphoma resistant to rituximab.Clin Cancer Res. 15: 851-7.
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.